Mutation in tumor suppressor gene p53, which is involved in cell-cycle control, DNA repair, and apoptosis, is the most prevalent mutation in ovarian cancer and is correlated with the resistance to chemotherapy and RT due to the annulment of p53-dependent apoptosis. This evidence concerns the gene TP53 and ovarian cancer.